Following the inaugural session the forum shifted gears with flagship Fireside Chat titled The India MedTech Opportunity spotlighting India’s emergence as a strategic priority for global MedTech leaders. Senior executives from Stryker, Intuitive Surgical and Fresenius Medical Care shared how India is now a strategic priority in boardroom decisions, thanks to its vast and diverse patient base, expanding healthcare infrastructure, and progressive policy landscape.

While challenges such as regulatory complexity and infrastructure gaps remain, the panel emphasized that success lies in building strong local partnerships, investing in skilled talent, and aligning with India’s vision of Viksit Bharat 2047. The session resonated with the forum’s overarching theme, “Swastha Bharat – A Healthier India, Together,” reinforcing the country’s pivotal role in shaping the future of healthcare. Several insights and opportunities were discussed amongst the panelists – such as Robotics expected to grow 40% over the next few years in India, productivity of robotics in India is highest in the world, Stryker investing in a new facility in India to ramp up Artificial Intelligence capabilities.

In addition to the Fireside Chat, there were ten Leadership Dialogue sessions held across the two days of the 11th MedTech Forum.

• Day 1 of these dialogues began with a compelling session on Unlocking India for Global Leadership in MedTech, where speakers highlighted the country’s strengths in innovation, regulatory reform, and talent development as critical enablers of global competitiveness.
• This was followed by Innovation Without Limits, a thought-provoking discussion that urged and challenged the industry to move beyond incremental progress and embrace bold, transformative innovations—supported by long-term policy vision and infrastructure readiness.
• The third dialogue, MedTech for All, Delivering Value, Driving Outcomes, focused on democratizing access to healthcare technologies. Leaders discussed how innovation must be inclusive, translating into tangible health outcomes for diverse populations across urban and rural settings.
• The final dialogue of Day 1, Powering Up, Investing in India’s MedTech Future addressed the financial and strategic investments needed to scale India’s MedTech ecosystem. From private equity to public partnerships, the conversation highlighted the importance of building resilient supply chains, fostering local manufacturing, and enabling global market access.

Day 2 of the forum featured a dynamic lineup of leadership dialogues that explored the future of MedTech through the lenses of innovation, investment, accessibility, and emerging technologies.

• The fifth leadership dialogue, CTRL + HEAL: How AI is Rebooting MedTech focused on the transformative role of AI in healthcare. Industry and government leaders discussed AI deployment across MedTech value chain, the vision for unified health data systems, and the need to upskill the workforce to effectively leverage AI tools.
• Next dialogue, Regulatory Agility in an Age of Disruption addressed how emerging technologies like digital health and personalized medicine require more adaptive and responsive regulatory frameworks. Regulatory experts from India, Malaysia, Singapore, and Australia shared real-world examples of how regulatory bodies are responding to innovation without compromising safety and access.
• The seventh session, India Rising – MedTech in a New Global Order, explored India’s growing influence in global healthcare through strategic partnerships with the US, UK, and EU. The dialogue highlighted India’s potential in high-value manufacturing, cross-border R&D, and the development of trade corridors that can unlock its full MedTech potential.
• Eighth dialogue, Innovation & Care – A Payor, Provider, MedTech Dialogue examined how India’s push toward Universal Health Coverage by 2030 intersects with reimbursement reforms and market access. Leaders from hospitals, insurance, and MedTech discussed how collaborative models can drive sustainable growth and improve patient access to advanced technologies.
• The ninth dialogue, Expanding Diagnostic Access Across India, focused on strategies to improve access to advanced diagnostics in Tier 2 and Tier 3 regions. With nearly 300,000 diagnostic labs across the country and nearly one-third of diagnostic revenue originating from Tier 3 cities and below, the session underscored the critical importance of decentralizing healthcare delivery. Leaders spotlighted the need for a strengthened ecosystem—covering regulatory support, IT infrastructure, workforce capabilities, and supply chain efficiency—to enable timely and equitable diagnosis for underserved populations. The dialogue highlighted how expanding diagnostic access is not only a public health imperative but also a significant opportunity for innovation and investment in India’s rapidly evolving MedTech landscape
• The tenth and final session of the two days long forum, Innovation – Legal and Ethical Considerations, addressed the complex legal and ethical dimensions of MedTech innovation. Panelists explored themes such as regulatory compliance, data privacy, cybersecurity, and the importance of training and education to ensure responsible adoption of emerging technologies.

Across two days of rich dialogue and collaboration, the 11th APACMed MedTech Forum 2025 showcased India’s growing leadership in the MedTech space. From innovation and investment to accessibility and regulation, the sessions reflected a shared commitment to advancing MedTech in ways that are inclusive, sustainable, and globally impactful.

IQVIA MedTech is proud to be part of this journey and looks forward to continuing our engagement with the ecosystem as India moves toward its vision of Viksit Bharat 2047.

Click the contact us button on this page to arrange a consultation with our IQVIA MedTech team.